1. Controversy on the time to progression of pancreatic ductal adenocarcinoma. Issue 11 (2nd March 2015) Authors: Gallmeier, Eike; Hernaez, Ruben; Gress, Thomas M Journal: Gut Issue: Volume 64:Issue 11(2015) Page Start: 1676 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CUX1 mediates tumour cell survival: implications for future therapies?. Issue 8 (16th July 2010) Authors: Malek, Nisar P Journal: Gut Issue: Volume 59:Issue 8(2010) Page Start: 1014 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?. Issue 1 (3rd November 2016) Authors: Hessmann, Elisabeth; Johnsen, Steven A; Siveke, Jens T; Ellenrieder, Volker Journal: Gut Issue: Volume 66:Issue 1(2017) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. Issue 6 (21st October 2016) Authors: Bao, Ying; Prescott, Jennifer; Yuan, Chen; Zhang, Mingfeng; Kraft, Peter; Babic, Ana; Morales-Oyarvide, Vicente; Qian, Zhi Rong; Buring, Julie E; Cochrane, Barbara B; Gaziano, J Michael; Giovannucci, Edward L; Manson, JoAnn E; Ng, Kimmie; Ogino, Shuji; Rohan, Thomas E; Sesso, Howard D; Stampfer, ... Journal: Gut Issue: Volume 66:Issue 6(2017) Page Start: 1116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SiRNA-coupled nanoparticles for improved therapeutic targeting of pancreatic cancer. Issue 11 (19th July 2016) Authors: Lange, Sebastian; Saur, Dieter; Rad, Roland Journal: Gut Issue: Volume 65:Issue 11(2016) Page Start: 1780 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages. Issue 11 (30th January 2015) Authors: Yu, Jun; Blackford, Amanda L; dal Molin, Marco; Wolfgang, Christopher L; Goggins, Michael Journal: Gut Issue: Volume 64:Issue 11(2015) Page Start: 1783 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer. Issue 11 (12th May 2016) Authors: Mahajan, Ujjwal M; Teller, Steffen; Sendler, Matthias; Palankar, Raghavendra; van den Brandt, Cindy; Schwaiger, Theresa; Kühn, Jens-Peter; Ribback, Silvia; Glöckl, Gunnar; Evert, Matthias; Weitschies, Werner; Hosten, Norbert; Dombrowski, Frank; Delcea, Mihaela; Weiss, Frank-Ulrich; Lerch, Markus ... Journal: Gut Issue: Volume 65:Issue 11(2016) Page Start: 1838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗